Changes in motor function and quality of life after surgery in patients with pancreatic cancer
概要
1
Changes in motor function and quality of life after surgery in patients with pancreatic cancer
2
3
Yuki Nakashima,1,5) Toshihiro Kawae,2) Daisuke Iwaki,1) Kenichi Fudeyasu,1) Hiroaki Kimura,3)
4
Kenichiro Uemura,4) Hitoshi Okamura5)
5
6
1
7
Japan
8
2
9
3
10
4
11
University, Hiroshima, Japan
12
5
13
Sciences, Hiroshima University, Japan
Division of Rehabilitation, Department of Clinical Support, Hiroshima University Hospital,
Department of Physical Therapy, Faculty of Makuhari Human Care, Tohato University, Japan
Department of Rehabilitation Medicine, Hiroshima University Hospital, Japan
Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima
Department of Psychosocial Rehabilitation, Graduate School of Biomedical and Health
14
15
16
17
18
19
20
21
22
23
24
25
1
26
Abstract
27
28
Objective: To determine the changes in motor function and health-related quality of life after
29
pancreatectomy and identify factors influencing postoperative quality of life.
30
Methods: This study was a single-center prospective observational study. The 6-min walking
31
distance, grip strength, knee extension strength, and health-related quality of life variables were
32
measured in patients with pancreatic cancer before and after surgery. The paired t-test and the
33
Wilcoxon signed-rank test were used to compare the pre-and postoperative motor function and
34
health-related quality of life variables. Factors associated with postoperative health-related
35
quality of life were assessed using multiple regression analysis.
36
Results: Fifty-nine individuals were enrolled. Motor function values decreased significantly
37
postoperatively compared with preoperatively, including the 6-min walking distance (mean ±
38
standard deviation: 402.5 ± 95.4 vs. 497.7 ± 80.4 m, P<0.001), knee-extensor strength (0.42 ±
39
0.10 vs. 0.47 ± 0.10 kgf/kg, P<0.001), and grip strength (22.0 ± 8.9 vs. 24.5 ± 9.2 kg, p <
40
0.001). Multiple regression analysis showed significant association between 6-min walking
41
distance change and postoperative physical functioning scores of health-related quality of
42
life (p = 0.036).
43
44
45
46
Conclusion: Motor function decreased postoperatively. Our findings suggest that a decrease in 6min walking distance after surgery may be associated with postoperative physical functioning scores of
EORTC QLQ-C30 in pancreatic cancer patients.
47
48
Key words: Pancreatectomy, cancer, muscle strength, surgery, quality of life, walking
49
50
51
2
52
Introduction
53
54
Pancreatic cancer is one of the leading causes of cancer-related mortality in developed
55
countries (Ferlay et al, 2013). Actually, more than 331,000 deaths per year - accounting for
56
4.0% of all cancer-related deaths - are attributed to this disease, making it the seventh leading
57
cause of such deaths in men and women combined (Ferlay et al, 2013). In recent years, the
58
death rate from pancreatic cancer has been increasing, and it is anticipated that this rate will
59
continue to increase in the future (Rahib et al, 2014; Katanoda et al, 2015).
60
Surgical resection is the only curative treatment for pancreatic cancer (Tempero et al, 2017),
61
and postoperative adjuvant chemotherapy has been shown to improve life expectancy in
62
randomized controlled trials (Oettle et al, 2007; Oettle et al, 2013). Adjuvant chemotherapy is
63
initiated approximately 2–10 weeks after the surgery, although the Karnofsky performance
64
status score is required to be >50 for its administration (Ueno et al, 2009; Oettle et al, 2007;
65
Oettle et al, 2013). Early postoperative mobilization is strongly recommended to prevent
66
postoperative complications; however, there have been no studies on the influence of
67
perioperative exercise therapy and motor function on the postoperative courses of patients who
68
underwent pancreatic cancer surgery. Therefore, there exists a lack of established exercise
69
therapy programs for such patients (Lassen et al, 2013).
70
In recent years, the importance of health-related quality of life (QOL) has been emphasized in
71
patients with cancer (Esbensen et al, 2004; Morishita et al, 2018; Hawthorn, 1993). It has been
72
shown that pancreatectomy reduces the health-related QOL in patients with pancreatic cancer
73
(Lounis et al, 2019; Halloran et al, 2011); these studies also found that pancreatectomy has a
74
major impact on motor and psychological functions.
75
Previous studies revealed that surgery is associated with decreased motor function in patients
76
with esophageal and colorectal cancers (Tatematsu et al, 2013; Inoue et al, 2016; Olsén et al,
77
2005; Sánchez-Jiménez et al, 2015). Therefore, given that surgery for pancreatic cancer is more
3
78
invasive than that for colorectal cancer, motor function is also expected to decrease after
79
pancreatectomy. However, very few studies have objectively investigated motor function in
80
patients with pancreatic cancer(Hayashi et al, 2017), and there are no longitudinal studies that
81
have compared motor function before and after surgery despite their potential importance in
82
establishing perioperative rehabilitation programs. Additionally, health-related QOL is also
83
expected to decrease after surgery; however, the effect of motor function on the postoperative
84
health-related QOL is also unclear.
85
Therefore, we aimed to determine the effect of surgery on the motor function and health-
86
related QOL in patients with pancreatic cancer, and to identify factors that influence the
87
postoperative health-related QOL.
88
89
Methods
90
91
We conducted a single-center prospective study to investigate the effect of pancreatic
92
resection on the motor function and health-related QOL in patients with pancreatic cancer. This
93
study was approved by the redacted Epidemiological Ethics Review Board (approval number:
94
E-656), and the patients provided written and verbal informed consent. All persons gave their
95
informed consent prior to their inclusion in the study. The survey period spanned from June
96
2017 to June 2019.
97
The inclusion criteria were: 1) pancreatectomy performed for suspected invasive ductal
98
carcinoma of the pancreas at our hospital during the aforementioned period; and 2) immediate
99
referral to the rehabilitation department. Patients who required assistance while walking owing
100
to motor organ and/or central nervous system disease, and those for whom the evaluation of
101
motor function was difficult, were excluded from the study.
102
103
As 6-min walking distance was primary endpoint. The 6-min walking distance was measured
as an index of exercise tolerance. Secondary endpoint as hand grip, knee extension strengths,
4
104
Health-related QOL. Hand grip and knee extension strengths were measured as indices of upper
105
and lower extremity muscle strength, respectively. Health-related QOL measures were assessed
106
by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life
107
Questionnaire (QLQ-C30) version 3.0. The investigations were conducted by physical
108
therapists. Patient information including age, sex, body weight, body mass index (BMI),
109
diagnosis, chemotherapy regimens received before surgery, preoperative blood levels of C-
110
reactive protein and albumin, surgical method, operation time, amount of blood loss, and
111
postoperative hospitalization duration were obtained from medical records.
112
Details of the administered evaluation tests are as follows:
113
1) In the 6-min walking test, 30-m walking courses were created in an indoor corridor according
114
to the guidelines of the American Thoracic Society statement (2002), with a cone installed to
115
indicate the turnaround point. Patients were instructed to walk the longest distance they could
116
cover during the 6-min period. Walking for 6 min is reportedly associated with peak oxygen
117
uptake in patients with cancer, and is, therefore, a valuable indicator (Schmidt et al, 2013).
118
2) Knee extensor muscle strength, which is considered an index of lower limb muscle strength,
119
was measured using an isometric muscle strength measuring device (μTas M-1, Anima Inc.,
120
Tokyo, Japan), while the isometric knee extensor strength was measured with a sensor pad
121
immobilized on a belt at the distal lower leg (Nomura et al, 2018). The measurement posture
122
was sitting at the edge of a chair, with both hands paired in front of the chest while the trunk
123
was kept in an upright position. The sensor pad was placed distal to the participant’s lower leg;
124
the height of the sitting surface and length of the fixation belt were adjusted to place the knee
125
joint at a 90° flexion, whereupon the belt was secured to the examination table. Isometric knee
126
extension exercises with maximum effort were performed for approximately 5 s twice on each
127
side, and the maximum value was adopted as the recorded knee extension strength. To eliminate
128
the effect of body weight, the knee extension strength-to-weight ratio divided by the maximum
129
isometric knee extension strength was calculated for normalization.
5
130
3) Grip strength measurement was performed using Smedley-type grip dynamometer while
131
being in the standing position with the upper extremity in a drooping stance. The grip size of a
132
dynamometer was adjusted until the second joint of the participant’s index finger was at a 90°
133
angle on the handle by examiner. The participants were instructed to grasp the device with their
134
maximum strength; the right and left hand strength was each tested twice, and the maximum
135
value was considered the grip strength.
136
4) The EORTC QLQ-C30 version 3.0, which comprises 30 questions for patients with cancer,
137
was used to investigate the health-related QOL. The scores were classified according to the
138
guidelines into five functional scales (physical, roles, cognitive, emotional, and social
139
functioning), three symptom scales (fatigue, pain, nausea/vomiting), and six single items
140
(constipation, diarrhea, insomnia, dyspnea, anorexia, and economic difficulties) and were
141
converted to an overall score ranging from 0 to 100 (Fayers et al, 2001).
142
Motor function and EORTC QLQ-C30 were evaluation at two points before and after
143
surgery. All participants in this study received the same physical therapy regimen during the
144
perioperative period. Preoperative guidance included respiratory training, postoperative physical
145
therapy orientation, and preoperative evaluation between 7 and 1 day(s) before surgery.
146
Postoperative rehabilitation was performed starting on postoperative day 1 and continued until
147
discharge. From the first postoperative day, the participants performed sputum drainage
148
exercises and rose from their beds. Resistance and aerobic exercises were performed starting on
149
postoperative day 4. Each patient performed a combination of resistance and aerobic exercise
150
for 20 to 40 minutes. The focus was on lower extremity resistance exercises such as leg presses,
151
leg extensions, hip adductions, hip abductions, and heel raises. Aerobic exercise included
152
bicycle ergometer and walking for 10 to 20 minutes. Postoperative evaluation was performed 14
153
days after surgery.
154
The sample sizes were calculated using a standard deviation of 88 m based on a previous
155
study, which examined the changes in 6-min walking times before and after gastrointestinal
6
156
surgery (Inoue et al, 2016). A decrease of 80 m during the 6-min walking test was considered
157
clinically meaningful (Wise and Brown, 2005). The required sample size for an α error of 0.05
158
and a β error of 0.2 was calculated to be 41 participants.
159
160
161
Statistical Analysis
162
Continuous variables were checked for normality using the Shapiro–Wilk test. Comparisons
163
between the two matched groups were performed using the paired t-tests for the 6-min walking
164
distance, grip strength, and knee-extension strength based on a normal distribution, and using
165
the Wilcoxon signed-rank tests for the EORTC QLQ-C30 without a normal distribution.
166
Pearson correlation coefficients were then calculated to assess relations among preoperative
167
motor function parameters and physical functioning scores of EORTC QLQ-C30, and the
168
relation between the delta change in physical functioning scores and motor function parameters.
169
Single regression analysis was followed by multiple regression analysis to investigate factors
170
associated with physical function scores, as determined by the postoperative QLQ-C30. We
171
chose physical functioning scores because physical functioning scores have been reported as an
172
independent prognostic factor in patients with pancreatic cancer (Gupta et al, 2006). In addition,
173
the 6 minutes walking distance for in patients with cancer correlates with the EORTC physical
174
functioning scores (K Schmidt et al, 2013, Morishita et al, 2018).
175
The JMP® 14 software (SAS Institute Inc., Cary, NC, USA) was used for all statistical
176
processing and analyses. All hypothesis tests were two-tailed. Single regression analysis was
177
performed to select explanatory variables for multiple regression analysis; variables with P-
178
values <0.20 were used as explanatory variables for multiple regression analysis. P-values
179
<0.05 were considered statistically significant.
180
181
7
182
Results
183
184
The patients’ selection process is presented in Figure 1. The patients’ characteristics and
185
surgical information are presented in Table 1. The median age was 66.5 years and the median
186
BMI was 21.5 kg/m2; 25(42%) and 34 (58%) participants were men and women, respectively.
187
Seventeen patients (29%) underwent preoperative chemotherapy. The median postoperative
188
hospital stay was 19 days and the median postoperative assessment time was at 14 days
189
postoperatively.
190
Table 2 shows the preoperative and postoperative 6-min walking distances, grip strength, and
191
knee-extensor strength test results; all variables significantly decreased after surgery. The
192
postoperative 6-min walking distance, grip strength, and knee extension strength were at 81%,
193
90%, and 89% of their presurgical values, respectively. In the EORTC QLQC-30, significant
194
decreases in physical, role, cognitive, social, and global functioning, fatigue, nausea and
195
vomiting, pain, insomnia, appetite loss, and diarrhea scores were observed after surgery
196
compared with their preoperative values (Table 3).
197
Regarding relations among preoperative motor function parameters and physical functioning
198
scores of EORTC QLQ-C30, except for the relationship between hand grip strength and
199
physical functioning scores, there was a significant relationship between each score (Table 4).
200
The delta change in physical functioning of EORTC QLQC30 was significant correlated with
201
the delta change in 6-min walk distance (r = 0.257; p = 0.0495), but not with the delta change
202
in % knee extension force (r = 0.048; p = 0.718) and hand grip strength (r = 0.075; p = 0.575).
203
To investigate the factors associated with the physical function scores, as derived from the
204
postoperative QLQ-C30, we performed a single-regression analysis using age, preoperative
205
serum albumin, preoperative C-reactive protein, surgical duration, blood loss, preoperative and
206
postoperative body weights, grip strength changes, knee-extension muscle strength changes, and
207
6-min walking distance changes as explanatory factors (Table 5). Subsequently, multiple
8
208
regression analyses were performed using blood loss, body weight change, and 6-min walking
209
distance change (i.e., factors with P-values < 0.20 on single-regression analyses) as explanatory
210
variables. Only the 6-min walking distance was found to be related to postoperative physical
211
function on multiple regression analysis (Table 4).
212
213
Discussion
214
215
This was the first prospective study to investigate motor function before and after surgery in
216
patients with pancreatic cancer. Our key finding was that motor functions, such as 6-min
217
walking distance, grip strength, and knee extension strength, decreased after pancreatectomy,
218
affecting the health-related QOL.
219
A previous study in patients with esophageal cancer revealed a decrease in the 6-min walking
220
length, grip strength, and knee-extensor strength following surgical treatment (Tatematsu et al,
221
2013). Moreover, another work showed that grip strength and lower extremity muscle strength
222
decreased in patients with colorectal carcinoma after surgery (Jensen et al, 2011). Furthermore,
223
in a cross-sectional study of patients with pancreatic cancer performed 107.9 ± 53.6 days after
224
pancreatectomy, muscle weakness of the upper and lower limbs was reported (Clauss et al,
225
2017). In our study, postoperative evaluation was performed after a median of 14 days
226
postoperatively, indicating that motor functions, such as muscle strength and exercise tolerance,
227
decline at an earlier stage.
228
Preventing such functional declines is important; despite receiving interventions, such as,
229
preoperative instruction included respiratory training and postoperative physical therapy
230
orientation. Postoperatively, patients were given walking from day 1 and resistance and aerobic
231
exercises from day 4. Each patient performed a combination of resistance and aerobic exercises
232
for 20 to 40 minutes. In spite of our participants experienced lower motor function, as
233
evidenced by decreases to 81%, 90%, and 89% of their 6-min walking distance, grasping power,
9
234
and knee extension muscle force, respectively, when compared to their preoperative values.
235
This was similar to previous studies in patients with other types of cancer (Tatematsu et al,
236
2013; Inoue et al, 2016), suggesting that the currently used in-hospital rehabilitation
237
interventions may not be sufficient to fully restore motor function after surgery. Additionally,
238
we found that many health-related QOL variables decreased postoperatively; this was consistent
239
with data from previous studies that found a significant reduction in the QOL immediately after
240
surgery (Schniewind et al, 2006; Heerkens et al, 2016). Moreover, our data also showed that the
241
change in 6-min walking distance was significantly associated with the postoperative physical
242
function scores as determined via the QLQ-C30. We hypothesized that the amount of change in
243
motor function after surgery compared to the amount of change in preoperative physical function in the
244
EORTC QLQ-C30 would affect postoperative physical function, and the amount of change in motor
245
function was used as an explanatory factor. This suggests that some rehabilitation for preventing a
246
decrease in the 6-min walking distance is needed to avert a decline in the postoperative QOL.
247
As aforementioned, our results suggest that commonly-used exercise therapies during
248
hospitalization, may not be sufficient to prevent the postoperative deterioration of motor
249
function. Recent studies have demonstrated the effectiveness of preoperative exercise therapy in
250
preventing postoperative motor dysfunction. In patients with colorectal carcinoma, undergoing
251
preoperative exercise therapy for approximately 1 month has been reported to improve the
252
postoperative 6-min walking distance (Li et al, 2013, Minnella, E. M et al, 2013). Preoperative
253
exercise has also been shown to be feasible in pancreatic cancer (Ngo-Huang, A et al, 2017),
254
and increasing physical activity has been shown to increase preoperative 6-minute walking
255
distance (Ngo-Huang, A et al, 2019).
256
In addition, significant weight loss was observed in the subjects of this study after surgery.
257
This was similar to previous studies in patients with pancreatic cancer after surgery (Hashimoto,
258
D et al, 2015). As weight has been used as one of the indicators of nutritional status in cancer
259
patients (Bauer, J et al, 2002), it can be inferred that the subjects in this study are in worse
10
260
nutritional status after surgery. Deterioration in nutritional status may affect motor function.
261
Such data suggest that preoperative exercise therapy and nutrition management may be
262
necessary for the early improvement of motor function in patients with pancreatic cancer.
263
There were some limitations in this study. First, it was a single-center investigation and,
264
therefore, did not necessarily reflect the general population. Second, although all participants in
265
this study received rehabilitation interventions during their hospitalization, the Enhanced
266
recovery after surgery(ERAS) protocol was not implemented at the hospital, as the ERAS
267
protocol facilitates recovery and reduces postoperative hospital stay (Ji, H. B et al, 2018), which
268
may help patients recover motor function and quality of life. Third, the duration of this study
269
encompassed only a short period of time before and after surgery. However, it would be more
270
informative to investigate the factors that impede motor function and QOL in a longitudinal
271
study spanning a longer period of time before and after surgery.
272
In conclusion, we found that the motor functions of patients with pancreatic cancer decreased
273
after surgery, and that the decrease in the 6-min walking distance was significantly associated
274
with a lower health-related QOL. Our data suggest that additional perioperative rehabilitation
275
should be considered to maintain postoperative motor function and health-related QOL in such
276
patients.
277
278
279
280
281
282
283
284
11
285
References
286
287
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.
288
(2002) ATS statement: Guidelines for the six-minute walk test. American Journal of
289
Respiratory and Critical Care Medicine, 166, 111–117. doi: 10.1164/ajrccm.166.1.at1102
290
Bauer, J., Capra, S., & Ferguson, M. (2002). Use of the scored Patient-Generated
291
Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients
292
with cancer. European journal of clinical nutrition, 56(8), 779–785.
293
https://doi.org/10.1038/sj.ejcn.1601412
294
Clauss, D., Tjaden, C., Hackert, T., Schneider, L., Ulrich, C.M., Wiskemann, J. and Steindorf,
295
K. (2017) Cardiorespiratory fitness and muscle strength in pancreatic cancer patients.
296
Supportive Care in Cancer, 25, 2797–2807. doi: 10.1007/s00520-017-3694-8
297
Esbensen, B.A., Østerlind, K., Roer, O. and Hallberg, I.R. (2004) Quality of life of elderly
298
persons with newly diagnosed cancer. European Journal of Cancer Care, 13, 443–453. doi:
299
10.1111/j.1365-2354.2004.00546.x
300
Fagevik Olsén, M., Larsson, M., Hammerlid, E. and Lundell, L. (2005) Physical function and
301
quality of life after thoracoabdominal oesophageal resection: Results of a longitudinal
302
follow-up study. Digestive Surgery, 22, 63–68. doi: 10.1159/000085348
303
Fayers, P.M., Aaronson, N.K., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A., on behalf
304
of the EORTC Quality of Life Group. (2001) EORTC QLQ-C30 Scoring Manual (3rd ed.).
305
Brussels: European Organisation for Research and Treatment of Cancer; 1–67.
306
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W.W., Comber, H.,
307
Forman, D. and Bray, F. (2013) Cancer incidence and mortality patterns in Europe:
308
Estimates for 40 countries in 2012. European Journal of Cancer, 49, 1374–1403. doi:
309
10.1016/j.ejca.2012.12.027
12
310
Gupta, D., Lis, C. G., & Grutsch, J. F. (2006). The European organization for research and
311
treatment of cancer quality of life questionnaire: implications for prognosis in pancreatic
312
cancer. International journal of gastrointestinal cancer, 37, 65–73.
313
https://doi.org/10.1007/s12029-007-0001-9
314
Halloran, C.M., Cox, T.F., Chauhan, S., Raraty, M.G., Sutton, R., Neoptolemos, J.P. and
315
Ghaneh, P. (2011) Partial pancreatic resection for pancreatic malignancy is associated with
316
sustained pancreatic exocrine failure and reduced quality of life: a prospective study.
317
Pancreatology, 11, 535–545. doi: 10.1159/000333308
318
319
320
Hawthorn, J. (1993) Measuring quality of life. European Journal of Cancer Care, 2, 77–81. doi:
10.1111/j.1365-2354.1993.tb00167.x
Hashimoto, D., Chikamoto, A., Ohmuraya, M., Abe, S., Nakagawa, S., Beppu, T., Takamori,
321
H., Hirota, M., & Baba, H. (2015). Impact of Postoperative Weight Loss on Survival After
322
Resection for Pancreatic Cancer. JPEN. Journal of parenteral and enteral nutrition, 39, 598–
323
603. https://doi.org/10.1177/0148607114520992
324
Hayashi, K., Yokoyama, Y., Nakajima, H., Nagino, M., Inoue, T., Nagaya, M., Hattori, K.,
325
Kadono, I., Ito, S., & Nishida, Y. (2017). Preoperative 6-minute walk distance accurately
326
predicts postoperative complications after operations for hepato-pancreato-biliary cancer.
327
Surgery, 161, 525–532. https://doi.org/10.1016/j.surg.2016.08.002
328
Heerkens, H.D., Tseng, D.S., Lips, I.M., Van Santvoort, H.C., Vriens, M.R., Hagendoorn, J.,
329
Meijer, G.J., Borel Rinkes, I.H., van Vulpen, M. and Molenaar, I.Q. (2016) Health-related
330
quality of life after pancreatic resection for malignancy. British Journal of Surgery, 103,
331
257–266. doi: 10.1002/bjs.10032
332
Inoue, T., Ito, S., Ando, M., Nagaya, M., Aso, H., Mizuno, Y., Hattori, K., Nakajima, H.,
333
Nishida, Y., Niwa, Y., Kodera, Y., Koike, M. and Hasegawa, Y. (2016) Changes in exercise
334
capacity, muscle strength, and health-related quality of life in esophageal cancer patients
13
335
undergoing esophagectomy. BMC Sports Science, Medicine & Rehabilitation, 8, 34. doi:
336
10.1186/s13102-016-0060-y
337
Jensen, M.B., Houborg, K.B., Nørager, C.B., Henriksen, M.G. and Laurberg, S. (2011)
338
Postoperative changes in fatigue, physical function and body composition: An analysis of
339
the amalgamated data from five randomized trials on patients undergoing colorectal
340
surgery. Colorectal Disease, 13, 588–593. doi: 10.1111/j.1463-1318.2010.02232.x
341
Ji, H. B., Zhu, W. T., Wei, Q., Wang, X. X., Wang, H. B., & Chen, Q. P. (2018). Impact of
342
enhanced recovery after surgery programs on pancreatic surgery: A meta-analysis. World
343
journal of gastroenterology, 24, 1666–1678. https://doi.org/10.3748/wjg.v24.i15.1666
344
Katanoda, K., Hori, M., Matsuda, T., Shibata, A., Nishino, Y., Hattori, M., Soda, M., Ioka, A.,
345
Sodue, T. and Nishimoto, H. (2015) An updated report on the trends in cancer incidence
346
and mortality in Japan, 1958-2013. Japanese Journal of Clinical Oncology, 45, 390–401.
347
doi: 10.1093/jjco/hyv002
348
Lassen, K., Coolsen, M.M., Slim, K., Carli, F., De Aguilar-Nascimento, J.E., Schäfer, M.,
349
Parks, R.W., Fearon, K.C., Lobo, D.N., Demartines, N., Braga, M., Ljunggvist, O. and
350
Dejong, C.H. (2013) Guidelines for perioperative care for pancreaticoduodenectomy:
351
Enhanced recovery after surgery (ERAS®) society recommendations. World Journal of
352
Surgery, 37, 240–258. doi: 10.1007/s00268-012-1771-1
353
Li, C., Carli, F., Lee, L., Charlebois, P., Stein, B., Liberman, A.S., Kaneva, P., Augustin, B.,
354
Wongyingsinn, M., Gamsa, A., Kim, D.J., Vassiliou, M.C. and Feldman, L. S. (2013)
355
Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer
356
surgery: a pilot study. Surgical Endoscopy, 27, 1072–1082. doi: 10.1007/s00464-012-2560-
357
5
358
Lounis, L., Aurran-Schleinitz, T., Turrini, O., Delpero, J.R. and Bréjard, V. (2019)
359
Psychological outcomes and quality of life in relation to pancreatectomy. Pancreas, 48,
360
471–479. doi: 10.1097/MPA.0000000000001279
14
361
Minnella, E. M., Awasthi, R., Loiselle, S. E., Agnihotram, R. V., Ferri, L. E., & Carli, F.
362
(2018). Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in
363
Esophagogastric Cancer Surgery: A Randomized Clinical Trial. JAMA surgery, 153, 1081–
364
1089. https://doi.org/10.1001/jamasurg.2018.1645
365
Morishita, S., Tsubaki, A., Fu, J.B., Mitobe, Y., Onishi, H. and Tsuji, T. (2018) Cancer
366
survivors exhibit a different relationship between muscle strength and health-related quality
367
of life/fatigue compared to healthy subjects. European Journal of Cancer Care, 27, e12856.
368
doi: 10.1111/ecc.12856
369
Ngo-Huang, A., Parker, N. H., Wang, X., Petzel, M., Fogelman, D., Schadler, K. L., Bruera, E.,
370
Fleming, J. B., Lee, J. E., & Katz, M. (2017). Home-based exercise during preoperative
371
therapy for pancreatic cancer. Langenbeck's archives of surgery, 402(8), 1175–1185.
372
https://doi.org/10.1007/s00423-017-1599-0
373
Ngo-Huang, A., Parker, N. H., Bruera, E., Lee, R. E., Simpson, R., O'Connor, D. P., Petzel, M.,
374
Fontillas, R. C., Schadler, K., Xiao, L., Wang, X., Fogelman, D., Sahai, S. K., Lee, J. E.,
375
Basen-Engquist, K., & Katz, M. (2019). Home-Based Exercise Prehabilitation During
376
Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical
377
Function and Quality of Life. Integrative cancer therapies, 18, 1534735419894061.
378
https://doi.org/10.1177/1534735419894061
379
Nomura, T., Ishiguro, T., Ohira, M. and Ikeda, Y. (2018) Diabetic polyneuropathy is a risk
380
factor for decline of lower extremity strength in patients with type 2 diabetes. Journal of
381
Diabetes Investigation, 9, 186–192. doi: 10.1111/jdi.12658
382
Oettle, H., Neuhaus, P., Hochhaus, A., Hartmann, J.T., Gellert, K., Ridwelski, K.,
383
Niedergethmann, M., Zulke, C., Fahlke, J., Arning, M.B., Sinn, M., Hinke, A. and Riess, H.
384
(2013) Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients
385
with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA, 310, 1473–
386
1481. doi: 10.1001/jama.2013.279201
15
387
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke,
388
J., Zuelke, C., Burkart, C., Gutberlet, K., Kettmer, E., Schmalenberg, H., Weigang-Koehler,
389
K., Bechstein W.O., Niedergethmann, M., Schmidt-Wolf, I., Roll, L., Doerken, B. and
390
Riess, H. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients
391
undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial.
392
JAMA, 297, 267–277. doi: 10.1001/jama.297.3.267
393
Rahib, L., Smith, B.D., Aizenberg, R., Rosenzweig, A.B., Fleshman, J.M. and Matrisian, L.M.
394
(2014) Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid,
395
liver, and pancreas cancers in the United States. Cancer Research, 74, 2913–2921. doi:
396
10.1158/0008-5472.CAN-14-0155
397
Sánchez-Jiménez, A., Cantarero-Villanueva, I., Delgado-García, G., Molina-Barea, R.,
398
Fernández-Lao, C., Galiano-Castillo, N. and Arroyo-Morales, M. (2015) Physical
399
impairments and quality of life of colorectal cancer survivors: a case-control study.
400
European Journal of Cancer Care, 24, 642–649. doi: 10.1111/ecc.12218
401
Schmidt, K., Vogt, L., Thiel, C., Jäger, E. and Banzer, W. (2013) Validity of the six-minute
402
walk test in cancer patients. International Journal of Sports Medicine, 34, 631–636. doi:
403
10.1055/s-0032-1323746
404
Schniewind, B., Bestmann, B., Henne-Bruns, D., Faendrich, F., Kremer, B. and Kuechler, T.
405
(2006) Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the
406
pancreatic head. British Journal of Surgery, 93, 1099–1107. doi: 10.1002/bjs.5371
407
Tatematsu, N., Hasegawa, S., Tanaka, E., Sakai, Y. and Tsuboyama, T. (2013) Impact of
408
oesophagectomy on physical fitness and health-related quality of life in patients with
409
oesophageal cancer. European Journal of Cancer Care, 22, 308–313. doi:
410
10.1111/ecc.12030
411
412
Tempero, M.A., Malafa, M.P., Al-Hawary, M., Asbun, H., Bain, A., Behrman, S.W., Benson,
A.B. 3rd, Binder, E., Cardin, D.B., Cha, C., Chiorean, E.G., Chung, V., Czito, B., Dillhoff,
16
413
M., Dotan, E., Ferrone, C.R., Hardacre, J., Hawkins, W.G., Herman, J., Ko, A.H. and
414
Darlow, S. (2017) Pancreatic adenocarcinoma, version 2.2017: NCCN clinical practice
415
guidelines in oncology. Journal of the National Comprehensive Cancer Network, 15, 1028–
416
1061. doi: 10.6004/jnccn.2017.0131
417
Ueno, H., Kosuge, T., Matsuyama, Y., Yamamoto, J., Nakao, A., Egawa, S., Doi, R., Monden,
418
M., Hatori, T., Tanaka, M., Shimada, M. and Kanemitsu, K. (2009) A randomised phase III
419
trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer:
420
Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. British Journal of
421
Cancer, 101, 908–915. doi: 10.1038/sj.bjc.6605256
422
Wise, R.A. and Brown, C.D. (2005) Minimal clinically important differences in the six-minute
423
walk test and the incremental shuttle walking test. COPD, 2, 125–129. doi: 10.1081/COPD-
424
200050
17
Table 1. Patient baseline characteristics
n=59
Age; years, mean (SD)
66.5 (11.6)
Body mass index; kg/m2, mean (SD)
21.5 (2.7)
Sex; n (%)
Male
25 (42)
Female
34 (58)
Hypertension; n (%)
18 (31)
Diabetes; n (%)
23 (39)
Hyperlipidemia; n (%)
16 (27)
Preoperative adjuvant therapy; n (%)
Yes
17 (29)
No
42 (71)
Preoperative serum albumin; g/dL, median (IQR)
3.60 (3.30–3.90)
Preoperative C-reactive protein; mg/dL, median (IQR)
0.11 (0.04–0.29)
Surgical procedure; n (%)
PPPD
34 (58)
DP
17 (29)
PD
4 (7)
DP-CAR
3 (5)
TP
1 (2)
Operative time; min, median (IQR)
304 (209–344)
Estimated blood loss; mL, median (IQR)
515 (277–795)
Postoperative hospital stays; days, median (IQR)
19 (17–25)
Postoperative evaluation day; days, median (IQR)
14 (12–17)
n: number, SD: standard deviation, IQR: interquartile range, PPPD: pylorus preserving
pancreaticoduodenectomy, DP: distal pancreatectomy, PD: pancreatoduodenectomy, DP-CAR:
distal pancreatectomy with celiac axis resection, TP: transduodenal papillectomy
18
Table 2. Differences in physical fitness and body weight before and after surgery
Preoperative
Postoperative
95% CI
P-value†
6MWD; m, mean (SD)
497.7 (80.4)
402.5 (95.4)
-110.8 – -79.6
<0.001
HGS; kg, median (IQR)
24.5 (9.2)
22.0 (8.9)
-3.8 – -2.3
<0.001
0.47 (0.10)
0.42 (0.10)
-0.06 – -0.03
<0.001
53.2 (10.9)
52.2 (10.1)
-3.6 – -2.2
<0.001
%KEF; kgf/kg, mean
(SD)
BW; kg, median (IQR)
6MWD: 6-min walk distance, HGS: hand grip strength, KEF: knee extension force, BW: body
weight, SD: standard deviation, IQR: interquartile range, CI: confidence interval, †: paired ttest
19
Table 3. Postoperative changes as determined using the EORTC QLQ‐C30
Condition
Preoperative
Postoperative
95% CI
P-value†
93.3 (86.7–100)
80.0 (66.7–86.7)
-19.0 – -10.6
<0.001
100.0 (66.7–100)
66.7 (33.3–66.7)
-34.0 – -19.7
<0.001
Cognitive functioning
83.3 (66.7–100)
66.7 (66.7–83.3)
-15.6 – -5.3
0.002
Emotional functioning
83.3 (66.7–91.7)
83.3 (66.7–91.7)
-10.0 – 5.5
0.620
Social functioning
83.3 (66.7–100)
66.7 (50.0–100)
-21.5 – -6.7
<0.001
Global functioning
66.7 (41.7–83.3)
50.0 (33.3–58.3)
-21.4 – -7.4
<0.001
Fatigue
22.2 (11.1–33.3)
44.4 (33.3–55.6)
16.5–27.9
<0.001
Physical functioning
Role functioning
Nausea and vomiting
0 (0–0)
16.7 (0–16.7)
-5.1–15.9
<0.001
Pain
0 (0–16.7)
33.3 (16.7–50)
16.2–29.0
<0.001
Dyspnea
0 (0–33.3)
33.3 (0–33.3)
3.1–16.1
0.007
Insomnia
0 (0–33.3)
33.3 (0–33.3)
8.5–23.1
<0.001
Appetite loss
0 (0–33.3)
33.3 (33.3–66.7)
26.7–45.6
<0.001
Constipation
33.3 (0–33.3)
33.3 (0–66.7)
-9.3–10.5
0.860
Diarrhea
0 (0–0)
33.3 (0–66.7)
23.0–43.6
<0.001
Financial difficulties
0 (0–33.3)
0 (0–33.3)
-0.02–13.6
0.020
Values are presented as the median (IQR). EORTC: European Organisation for Research and
Treatment of Cancer; QLQ-30: quality of life questionnaire-C30, IQR: interquartile range, CI:
confidence interval, †: Wilcoxon signed-rank test
20
Table 4. Relations among preoperative motor function parameters and physical functioning scores
of EORTC QLQ-C30
PF
PF
6MWD
-
6MWD
%KEF
HGS
0.397
0.279
0.173
(P=0.002)
(P=0.033)
(P=0.189)
0.323
0.374
(P=0.013)
(P=0.004)
-
%KEF
-
HGS
0.296
(P=0.023)
-
6MWD, 6-min walk distance; HGS, hand grip strength;KEF, knee extension force; PF,
physical functioning scores of EORTC QLQ-C30.
21
Table 5. Associations between indicators of relative decline in physical functioning score in the
EORTC QLQ-C30
Simple regression analysis
β
SE
-0.070
0.181
0.600
-0.161
4.619
0.223
0.120
5.576
0.366
Operative time
-0.016
0.020
0.902
Estimated blood loss
-0.222
0.002
δBW
-0.185
δHGS
Multiple regression analysis
β
SE
P-value
0.091
-0.105
0.003
0.437
0.793
0.160
-0.178
0.756
0.158
0.107
0.760
0.419
δKEF
0.018
29.342
0.895
δ6MWD
0.332
0.033
0.010
0.289
0.036
0.036
Age
P-value
Preoperative serum
albumin
Preoperative C-reactive
protein
BW: body weight, HGS: hand grip strength, KEF: knee extension force, 6MWD: 6-min walking
distance, SE: standard error
22
Surgery for suspected pancreatic cancer
(n=72)
Refusal of participate(n=3)
Preoperative survey (n=69)
Withdraw consent (n=5)
Lack of data (n=4)
Benign pathology (n=1)
Postoperative survey (n=59)
Excluded from analysis (n=0)
Figure 1. Flow diagram showing the selection of study participants
23